Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-11-25
1988-02-23
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540215, 540220, 540222, A61K 31545, C07D50112
Patent
active
047270705
ABSTRACT:
The antibiotic 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]ceph-3-em-4-c arboxylic acid (BMY-28100) forms imidazolidinone derivatives on reaction with ketones. These derivatives are useful in pharmaceutical dosage forms and as intermediates for separation thereof from mixtures containing the [(E)-1-propenyl]isomer of the antibiotic.
REFERENCES:
patent: 4339575 (1982-07-01), Ko'Oka et al.
patent: 4473567 (1984-09-01), Ko'Oka et al.
patent: 4520022 (1985-05-01), Hoshi et al.
Bogardus Joseph B.
Kaplan Murray A.
Lovell Michael W.
Bristol-Myers Company
Carnahan Robert E.
Cassatt Barbara
Daus Donald G.
LandOfFree
3-Propenzl cephalosporin isomer separation process and derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Propenzl cephalosporin isomer separation process and derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Propenzl cephalosporin isomer separation process and derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-603016